Although the results do not exclude existence of additional glycolytic players in ovarian cancer, inhibition of GLUT1 alone is sufficient to minimize glycolytic activity and growth of GLUT1-positive ovarian cancer cells. Here, SLC2A1 is linked to ovarian cancer.